Parvinder's son rises at Ranbaxy, Brar to exit
New Delhi: The Singh family has inched closer to once again occupying the corner office at Ranbaxy Laboratories Ltd, India's largest pharmaceutical company, say reports. Devinder Singh Brar, the CEO and managing director of the company, today announced that he would step down in July 2004, even as Malvinder Mohan Singh, the elder son of the late Parvinder Singh, was co-opted on the board and made second in command of the company. At a meeting of the Ranbaxy board of directors, Brar said he would not seek a renewal when his current term as CEO and managing director expires on July 4, 2002.

"Having fulfilled my role in the company, I would like to devote my time to other pursuits in the next 10-15 years of my working life," Brar told reporters later in the day indicating that his new venture might have something to do with pharmaceuticals. When asked if he would step down from the company's board as well, Brar said he would decide on it over the next few months.
Back to News Review index page